More recently, some studies have demonstrated that CXCR4 inhibition can reduce immunosuppression both by acting on Treg cells and myeloid derived suppressor cells (MDSC) that highly expressed CXCR4 receptor, overall resulting in the reactivation of T immune response against tumor cells (23–25). Here, CXCR4 is linked to neoplasm.